Vaccine-like immune treatment to prevent lung infections in seniors
Part of Immune system & allergy clinical trials.
This Phase 2 study tests a site-specific immune “booster” in people age 65 and older to help improve natural immunity and reduce respiratory (lung/airway) infections. You may be eligible if you can consent, are in an eligible living situation, and are not currently using certain immune-suppressing medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 65 or older
- You live in the community or in a participating long-term care, independent-living, or assisted-living facility
- You can sign informed consent yourself (no legal guardian consent listed)
- You’re not expected to die within the next 3 months
- You are not using immune-suppressing medicines like certain biologics or other strong immune blockers
- You haven’t taken systemic antibiotics or antivirals recently (within 30 days), and you aren’t currently being treated for an infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called OM 85 that may help prevent respiratory infections (like pneumonia) in older adults living in nursing homes. If you are 75 or older and have had infections recently, this trial could be a way to stay healthier.
This trial tests whether an immune defense protein can help reduce upper respiratory infections (like colds) in people aged 60 and older. It may be a good fit if you get colds or flu-like symptoms several times each season.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial is testing a new drug called QLS7305, given as a shot under the skin, to see if it is safe in healthy adults. It may help in the future to treat certain conditions.
This trial tests a new vaccine designed to help protect older adults from infections that can affect breathing. You might be able to join if you're in generally good health and meet the other requirements listed below.
This study tests whether a medication called rapamycin (sirolimus) can help improve your body's response to flu and RSV vaccines. You have end-stage kidney disease and receive dialysis three times a week, and the researchers want to see if this approach keeps you safer from these infections.
Hear when a new Immune Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.